Failure to isolate A/Fujian/411/2002 (H3N2) in embryonated chicken eggs resulted in its absence from the 2003/2004 vaccine. We analyzed the adaptation of this virus in eggs during serial passages in the amniotic then allantoic cavities. Amniotic passage allowed the virus to grow in the allantoic cavity. During adaptation, 6 amino acid substitutions occurred: 4 in HA (G186V, S219F, V226I, V309I) and 2 in NA (E119Q, Q136K). These substitutions allowed binding to SAα2,3Gal-and SAα2,6Gal-containing receptors, conferred SAα2,3Gal specificity, and preserved antigenicity. Two HA substitutions (G186V, V226I) were sufficient to improve growth. Changing 2 NA residues (E119Q, Q136K) did not improve growth, and adaptation did not result in the HA changes H183L, D188Y, and V226A found by others. These findings suggest that viral adaptation in eggs involves multiple strategies. Vaccine manufacture will benefit from increased understanding of adaptation and strategies to improve human influenza A virus replication in eggs.
Introduction
The principal means of protection against influenza is vaccination (Centers for Disease Control and Prevention, 2005) . Vaccines approved for use in the U.S. (inactivated or live attenuated vaccine) must contain components from an H1N1, an H3N2, and a B virus (i.e., the vaccine is trivalent). The H1N1 and H3N2 components are reassortant viruses having replicative genes from a master donor strain and the genes encoding the surface proteins, hemagglutinin (HA) and neuraminidase (NA), from circulating virus. The manufacture of trivalent vaccine relies upon large-scale cultivation of the 3 vaccine components in the allantoic cavity of chickens' eggs, and because of antigenic drift, the composition of the vaccine has to be reformulated annually (Gerdil, 2003) . The World Health Organization (WHO) predicted that, in the 2003/2004 influenza season, the virus A/Fujian/411/2002 (H3N2) (Fujian) would be the predominant strain. However, numerous attempts to grow this virus in the egg allantoic cavity in time for its inclusion in vaccine were unsuccessful. Thus, the only virus available was that isolated in non-validated MDCK cells. Virus isolated in this way cannot be used in vaccine manufacture. Consequently, the H3N2 component of the vaccine remained unchanged. Fujian did indeed predominate in the 2003/2004 season, and the mismatch between the circulating and vaccine strains resulted in an increase in influenza incidents, especially in children (Centers for Disease Control and Prevention, 2004) .
The method of isolating influenza virus in embryonated chickens' eggs was devised in the 1930s by Frank Macfarlane Burnet, who reported that influenza virus can be adapted for better growth by subjecting it to serial passages in the allantoic cavity (Burnet and Bull, 1943) . Human influenza A virus was later shown to be able to replicate unrestrictedly within the amnion and to replicate more efficiently in the allantoic cavity after initial amniotic passages . The amniotic and allantoic compartments of embryonated chickens' eggs possess receptors with different characteristics. A receptor's terminal sialic acid (SA) may be joined to galactose (Gal) by an α2,3 or an α2,6 linkage. Amniotic cells possess both types of receptors (SAα2,3Gal and SAα2,6Gal), whereas allantoic cells possess only the SAα2,3Gal receptor (Ito et al., 1997) . Influenza viruses bind to and recognize SAs in specific linkages, and the receptor-binding preferences of influenza viruses are specific to the animal species from which the virus was isolated. Human influenza A viruses, for example, preferentially bind to receptors in which 5-N-acetylneuraminic acid (Neu5Ac) is α2,6 linked to galactose (i.e., Neu5Acα2,6Gal receptors; ). Growth of virus in eggs can change the virus's receptor-binding specificity through alteration around the HA's receptor-binding sites (Azzi et al., 1993; Katz et al., 1987; Rocha et al., 1993; Williams and Robertson, 1993; Robertson et al., 1987) . Human influenza A viruses remain specific for SAα2,6Gal receptors when grown for up to 2 passages in the amniotic cavity, but after further allantoic passages, they acquire SAα2,3Gal specificity (Gambaryan et al., 1999; Ito et al., 1997) . However, the underlying mechanism of this adaptation remains unknown.
The use of embryonated chickens' eggs remains, until an alternative substrate is approved, the most economical and practical way to cultivate influenza viruses for vaccine production. Therefore, understanding the molecular basis for adaptation of the virus in eggs is crucial. The first objective of the present study was to identify which amino acids are altered during the adaptation of Fujian in eggs. Our next objective was to address the following key questions. First, what is the importance of these amino acids? A recent study using Fujian on an A/Ann Arbor/6/66 (H2N2) backbone (the master strain used to create live attenuated vaccine) indicated that amino acid changes that influence the activities of HA and NA can improve the virus's ability to replicate in the allantoic cavity (Lu et al., 2005) . Second, if a balance between HA and NA activities is crucial for efficient replication of influenza A virus (Lu et al., 2005; Wagner et al., 2002) , does this balance also play a role in the egg growth of Fujian on a different backbone? Third, because adaptation in eggs is associated with alteration of receptor-binding properties (Gambaryan et al., 1999) , does Fujian undergo changes in receptor specificity during adaptation? Finally, because the preservation of antigenicity is important in vaccine manufacture, we examined the relation between the amino acids we observed to be involved in the adaptation process and viral antigenicity.
Results

Amino acid substitutions observed during the adaptation of Fujian in embryonated chicken eggs
To identify the amino acid residues involved in adaptation in eggs, we examined the virus at each step of the adaptation process ( Fig. 1 ). We detected virus by using the hemagglutination assay. Each passage began with inoculation of 3 groups of 5 eggs: 1 group via the amniotic cavity (AM), 1 via the allantoic cavity (AL), and 1 via both routes (AM/AL).
First, we inoculated the eggs with Fujian that had been propagated in Madin-Darby canine kidney (MDCK) cells. After 48 h, we detected virus only in the amniotic fluid of 1 of the 5 eggs of the AM/AL group (Fig. 1 , "Inoculum route and virus growth"). This virus had 2 altered amino acids: V309I in HA and Q136K in NA (Fig. 1 , bottom 2 panels). We then injected this virus into a second set of 15 eggs. After this second passage, we harvested virus from the amniotic fluid of 2 eggs of the AM/AL group. This virus had the same 2 amino acid changes as the previous one and no additional changes. We continued to perform serial passages in a similar fashion (using the virus isolated after the previous passage to inoculate the next set of eggs) for a total of 6 passages, fully sequencing the progeny virus at each step. Replication of the virus improved after each passage, with virus being detectable in increasing numbers of inoculated eggs. After the fourth passage, we began to detect virus in the allantoic cavity, and from here on, we injected virus only into the allantoic cavity. After 2 additional passages, we detected virus in all inoculated eggs. These viruses had 4 amino acid changes in HA (G186V, S219F, V226I, and V309I), but only 1 change in NA (Q136K). A second change in NA (E119Q) was observed after passage 3, but reverted after passage 5. We observed no amino acid changes in proteins other than HA and NA.
This experiment showed that initial growth of the virus in the amniotic cavity increases the virus's replication efficiency in the allantoic cavity, as has been shown previously . Three passages in the amniotic cavity were needed to achieve replication in the allantoic cavity. However, further passages in the allantoic cavity were necessary for full adaptation in the allantoic cavity. Our sequence data indicate that replication in the allantoic cavity may require 1 amino acid change in NA (E119Q) but that additional changes around the globular head region of HA are necessary to establish a full adaptation in the allantoic cavity. Finally, we identified 6 amino acid changes (4 in HA and 2 in NA) that appear to be implicated in the adaptation of Fujian in embryonated chickens' eggs.
The importance of the amino acid residues observed in egg adaptation
To confirm that these amino acid changes improve the replication of Fujian in the allantoic cavity, we used reverse genetics to generate viruses with wild-type or adapted Fujian HA, NA, or both on a backbone of A/Puerto Rico/8/34 (H1N1) (PR8, the master strain used to generate inactivated vaccine). All viruses generated replicated in MDCK cells, but only that bearing the HA and NA of the adapted Fujian grew to a high titer in the allantoic cavity (Table 1) .
To determine which of the Fujian's surface proteins is responsible for its inability to grow in eggs, we generated PR8-based viruses bearing the Fujian HA or NA. That carrying the wild-type HA replicated poorly in the allantoic cavity (Table 1 , virus 1c), whereas that carrying wild-type NA replicated well (virus 1d). This result suggests that the responsibility for Fujian's inability to grow in eggs lies with the HA.
We then examined PR8-based viruses that had the Fujian HA or NA (or both) containing 1 or more of the substitutions found in the adapted virus. Viruses bearing wild-type HA and NA with 1 substitution (E119Q or Q136K) replicated at low titer (Table  1 , viruses 2e and 2f, respectively), as did those bearing wildtype NA and HA with 1 change (G186V, S219F, V226I, or V309I; viruses 2a-2d). Viruses with these singly substituted HAs and NA with the substitution Q136K also replicated poorly (data not shown and Table 1 , virus 5a).
Interestingly, virus with the HA substitutions G186V and V226I and wild-type NA replicated well in the allantoic cavity (Table 1, virus 3b); the titer of the same virus with the additional NA substitution Q136K was slightly lower (data not shown). The other 2 combinations of HA substitutions (G186V and S219F or S219F and V226I) with wild-type NA or Q136Ksubstituted NA conferred poor replicative ability (Table 1 , viruses 3a and 3c, respectively; and data not shown).
Virus with 3 changes in the HA (G186V, S219F, and V226I) and wild-type NA replicated well in the allantoic cavity (Table  1 , virus 4a), as did the same virus with the NA substitution Q136K (data not shown). In contrast, viruses with the other 3 HA substitutions (either G186V, S219F, and V309I or S219F, V226I, and V309I) and wild-type NA (Table 1 , viruses 4b and 4c, respectively) replicated to a much lower titer.
We also generated PR8-based viruses bearing Fujian HA or NA (or both) with the amino acid substitutions we observed at each passage during adaptation in eggs (Table 1 , groups 1 and 5). Virus corresponding to that resulting from the first 2 passages (HA, V309I; NA, Q136K) grew at a low titer in the allantoic cavity (Table 1 , virus 5a). Virus corresponding to those resulting from the third and fourth passages (HA, V309I; NA, E119Q and Q136K) also grew at a low titer (Table 1, virus 5b). However, viruses with V309I in the HA and a single mutation in the NA (E119Q or Q136K) replicated to a slightly lower titer than did those with both mutations in the NA (Table 1 , viruses 5c and 5a, respectively). Virus corresponding to those obtained at passages 5 and 6 (HA with G186V, S219F, V226I, and V309I; NA with Q136K; Table 1 , virus 1b) replicated to a titer similar to that of the same virus with wild-type Fujian NA (Table 1, 
virus 5d).
These results indicate that the most important factor in the inability of Fujian to grow in eggs is the HA. Most important in adaptation in the allantoic cavity were the HA mutations G186V Fig. 1 . Passage history and sequence changes required for replication of Fujian in embryonated chicken eggs. The row labeled "Inoculum route and virus growth" indicates the egg compartment (amniotic or allantoic fluid) from which the virus was isolated and, in parentheses, the numbers of positive eggs per group (5 eggs each) inoculated by the route indicated (AM/AL, both amniotic and allantoic; AM, amniotic; AL, allantoic). The bold and underline routes indicate the pooled source of inoculum for the subsequent passage, for example, in passages 2 and 3, the inoculum was derived from amniotic fluid. The next row ("inoculum titer") indicates the hemagglutination titer of the virus inoculated into eggs in the subsequent passage. At each passage level, each positive single egg harvest is sequenced, but pooled harvest is used as inoculum for subsequent passage. The amino acid sequence changes observed after each passage are shown on the structures of the trimeric HA molecule (only 1 monomer is shown) and the NA molecule. and V226I. Changes in NA appear to be necessary only in the first step of adaptation.
Relation between NA activity and virus replication in eggs
A balance between HA and NA activities is crucial for the efficient replication of influenza A virus (Wagner et al., 2002) : altered activity of either protein will affect viral replication. We have shown (above) that changes in HA result in better replication in eggs. Next, we examined the effects of the observed changes in the Fujian's NA on NA activity and the ability of the virus to replicate in eggs. NA activities in the 3 mutant viruses (NA with E119Q, Q136K, or both substitutions) were similar and lower than that of virus with wild-type Fujian NA on a PR8 backbone (Fig. 2 ). In addition, plaque assay (Table 1 and data not shown) showed that most of the PR8based viruses with the NA mutation(s) E119Q, Q136K, or both produced smaller plaques (<1.5 mm) than did those with wildtype Fujian NA (>1.5 mm), with the exception of 1 PR8-based virus with V309I in HA and wild-type Fujian NA, which produced small plaques (<1.5 mm; Table 1 , virus 2d). These results show that NA activity is reduced during adaptation in eggs.
Receptor specificity changes accompanying egg adaptation
Adaptation in eggs is associated with alteration of receptorbinding properties (Gambaryan et al., 1999) . We performed a rigorous chemical assay to determine the receptor-binding specificities of mutant viruses, i.e., which type of receptor (α2,3 or α2,6) is being bound by these viruses. We took our panel of viruses and measured their affinities to high molecular weight SA substrates, both natural (fetuin) and synthetic (3′-and 6′sialyllactose attached to a polyacrylic carrier: p3′SL representing the α2,3 linkage, and p6SL representing the α2,6 linkage) ( Table 2) . These sialyl molecules contain carbohydrate chains of natural glycoproteins and glycolipids, which are potential receptors for influenza A viruses. In this assay, the lower the dissociation constant (K diss ), the stronger the bond between virus and receptor. Fetuin contains both α2,3 and α2,6 linked sialic acids of complex compositions and is used as a positive binding control.
We found that the wild-type virus and virus carrying HA with the single substitution V309I have negligible affinity to the p3′SL and p6SL substrates ( Table 2) . Viruses bearing HA with the single mutation G186V or V226I exhibited affinity to both synthetic substrates, but their affinity to p3′SL was approximately 10 times as high as that to p6SL. Similarly, viruses with double or triple amino acid substitutions in the HA (G186V and V226I or G186V, V226I, and V309I) had a higher affinity to p3′SL than to p6SL. One virus carrying HA with the single mutation S219F bound only to p3′SL ( Table  2 ). The results show that mutations that improve replication in the allantoic cavity promote increased affinity of the virus to both α2,3and α2,6-linked SA. However, because the viruses' affinity to p3′SL is higher than that to p6SL, we conclude that improved replication in eggs is associated with the acquisition of specificity to mainly α2,3-containing receptors.
Relation between antigenicity and the mutations observed during adaptation in eggs
Vaccine manufacture requires that the modified virus preserves the antigenicity of the original. To determine whether the changes that permit virus replication in the allantoic cavity affect antigenicity, we performed hemagglutination inhibition (HI) and NA inhibition (NI) assays on all reverse genetics viruses that replicated well in the allantoic cavity using antisera and monoclonal antibodies (mAbs) ( Table 3) .
We were unable to detect any antigenic variation between wild-type and adapted viruses. Likewise, the adaptation process did not result in antigenic variation in NA as measured by NI assay (Table 3 ). We therefore conclude that, on a PR8 backbone, the various amino acid substitutions we observed during adaptation do not substantially influence virus antigenicity. We found no correlation between the specific mutation(s) in HA (G186V, S219F, V226I, or V309I) or in NA (E119Q or Q136K) and HI or NI titers.
Discussion
We have studied the molecular basis of the adaptation of viruses in eggs by analyzing the adaptation of A/Fujian/411/ 2002 (H3N2) (Fujian), a variant that grows poorly in the egg's allantoic cavity. We observed 6 amino acid changes (4 in HA and 2 in NA) during the adaptation of Fujian in eggs. To establish replication in the allantoic cavity, at least 3 passages in the amniotic cavity and 1 substitution in NA (E119Q) were needed. However, to establish full adaptation in the allantoic cavity, subsequent passages in the allantoic cavity and additional changes around the globular head region of HA were necessary. Our data show that 2 substitutions (G186V and V226I) in the Fujian HA on a PR8 backbone are sufficient to improve the growth of the virus in eggs. Those substitutions affect the virus's ability to bind to both α2,3and α2,6 linkage receptors and are responsible for the acquisition of specificity to SAα2,3Gal receptors, but do not affect viral antigenicity.
A report on a similar theme was recently published by Lu et al. (2005) . Briefly, they found that the growth of Fujian on an A/ Ann Arbor/6/66 (H2N2) backbone in eggs is improved if HA and NA activities are balanced by alteration of at least 2 HA residues (G186V and V226I or H183L and V226A) or at least 2 NA residues (E119Q and Q136K). We also found that the replication of Fujian is improved by introducing 2 substitutions into HA, G186V and V226I, which were selected during adaptation. However, our findings are different in that changing at least 2 NA residues (E119Q and Q136K) did not improve virus replication in the allantoic cavity, and we did not observe the HA substitutions H183L and V226A in our adaptation experiment. Interestingly, Nicolson et al. (2005) found that egg adaptation of 6+2 PR8/Fujian reassortant virus rescued in Vero cells was associated with 2 substitutions in HA (H183L and D188Y) and no sequence differences in NA. These different adaptive mutations demonstrate that there are multiple ways to improve the replication of Fujian in the allantoic cavity of embryonated chicken eggs. Selection of the adaptive mutations may vary depending on the backbone used (Lu et al., 2005 used A/Ann Arbor/6/66 (H2N2); we used PR8) or on the adaptive process used (Nicolson et al., 2005 took virus from Vero cells to the allantoic cavity; ours went from the amniotic cavity to the allantoic cavity).
In addition, by performing serial passages in the amniotic and allantoic cavities, we were able to study the time course of the adaptation of wild-type Fujian in eggs and to pinpoint the amino acids that contribute to the adaptation process. Our results suggest that the progression of adaptation in eggs can be described in 3 steps, and we propose the following hypotheses for each step. First, MDCK-grown Fujian (and presumably clinical isolates) can replicate in the amniotic cavity because the cells of the amniotic cavity in embryonated chicken eggs possess receptors with α2,6 linkages, which are preferred by human influenza A virus. Second, variants that can grow in the amniotic cavity have balanced HA and NA activities; some of these variants might successfully establish replication in the allantoic cavity, where only SA(α2,3)Gal-containing receptors exist. Finally, the virus achieves high growth in the allantoic cavity as a result of additional changes in HA that compensate for the low NA activity and restore the balance between the HA and NA activities. The changes in NA appear to be necessary for amniotic growth but not for allantoic growth. These observations emphasize the significance of a balance between HA and NA activities in virus replication (Wagner et al., 2002) : gain of function in 1 protein may compensate for the loss of function in the other. Data such as this allow for 2 possible strategies to make a potential vaccine reference strain from Fujian: i) passage of clinical material in amniotic cavities until allanotic adapted or ii) use of reverse genetics to clone HA and NA (this can be done from MDCK isolated virus), the introduction of necessary adaptive mutations into HA (G186V and V226I), then rescue of a 6+2 PR8 reassortant in validated cells such as Vero cells.
To determine the effect of the adaptation on receptor specificity, we used a rigorous chemical assay. According to our chemical assay, viruses bearing HA with either G186V or V226I bound to both SAα2,3Gal-and SAα2,6Gal-containing receptors but with higher affinity to the former. Interestingly, double substitution (G186V and V226I) in HA resulted in an increase in virus affinity that was similar to that resulting from single substitution, yet such double substitution virus had clear greater advantage in the allantoic cavity. This observation suggests that Fujian gained its efficient replication in eggs by some mechanism other than improved affinity alone, perhaps by binding to additional residues in an oligosaccharide receptor. In addition, viruses with the HA mutation G186V or V226I replicated better than did virus with the single HA mutation S219F. Consistently, virus with the substitution G186Vor V226I bound to both types of receptors, whereas virus with the HA substitution S219F bound only to SAα2,3Gal-containing receptor. Positions 186, 219, and 226 are all located within the receptor-binding pocket of H3 HA. Positions 186 and 226 are located in areas that have potential interactions with both SAα2,3Gal-and SAα2,6Gal-containing receptors, although they are closer to the binding site of SAα2,3Gal-containing receptors (Eisen et al., 1997) . As such, changes in these positions affect binding to both substrates, although they have more impact on binding to SAα2,3Gal-containing receptors. Position 219, in contrast, is located in a position that interact with SAα2,3Gal-containing receptors but is hindered for interaction with SAα2,6Gal-containing receptor by other amino acid residues at positions 165, 189, 218, 221, and 246 . Until now, description of influenza virus receptor specificity has primarily been limited to the differential recognition of Neu5Acα2,3Gal and Neu5Acα2,6Gal moieties. Moreover, adaptation of human influenza virus in eggs has been associated with increased affinity for SAα2,3Gal-containing receptors and decreased affinity for SAα2,6Gal-containing receptors (Gambaryan et al., 1999) . We have demonstrated that adaptation of Fujian in eggs is associated with binding to both types of receptors and that the affinity of binding to SAα2,3Gal-containing receptor is stronger than that to SAα2,6Gal-containing receptor. The change in virus receptor specificity associated with adaptation in eggs correlates with mutations at positions 186 and 226 in HA (Gambaryan et al., 1999; Matrosovich et al., 1993; Vines et al., 1998) . Our data have demonstrated that substitutions around the HA receptor-binding site can modulate the receptor specificity of influenza viruses in subtle but biologically important ways.
In addition to substitutions around the receptor-binding site of HA (Robertson et al., 1987; Rocha et al., 1993; Williams and Robertson, 1993) , an alteration in the stalk region of HA (V309I) was also found. Despite its early appearance during adaptation and its presence in viruses isolated in subsequent passages, this mutation did not play a role in the replication of virus generated by reverse genetics on a PR8 backbone. Viruses with at least 1 mutation in the ectodomain of HA, in or near the fusion peptide, have been shown to have an elevated pH for membrane fusion during adaptation to MDCK cells (Lin et al., 1997) . In addition, a recent study by Giannecchini et al. showed that there was a change in the pH of fusion accompanying the adaptation of a duck virus to turkey (Giannecchini et al., 2006) . Our finding of a similar change near the fusion region suggests that the passage of virus in eggs also results in the selection of mutants with an altered fusion pH. Although it is also possible that the V309I substitution is spurious, it is tempting to speculate that such changes in or around the fusion peptide are important steps in the adaptation process to different hosts or substrates.
Overall, this study has shown that more than 1 approach can be taken to reveal new ways to improve human influenza A virus replication in the allantoic cavity of eggs. An understanding of adaptation at the molecular level will benefit attempts to enhance human influenza A virus replication in the substrates used for vaccine manufacture and, consequently, will help public health authorities to achieve the important goal of increasing the availability of influenza vaccine.
Materials and methods
Virus strain, cells, and medium
The influenza A virus used in this study, A/Fujian/411/2002 (H3N2), was obtained from the Centers for Disease Control and Prevention (CDC), Atlanta, GA and propagated in MDCK cells (from the American Type Culture Collection [ATCC], Manassas, VA). MDCK cells were cultured in minimal essential medium (MEM) supplemented with 5% fetal bovine serum (FBS) and antibiotics. 293T human embryonic kidney cells (ATCC) were cultured in OptiMEM I (Gibco, Grand Island, NY) supplemented with 5% FBS and antibiotics.
Cloning of viral segments, construction of plasmids, and mutagenesis
Reverse transcription polymerase chain reaction (RT-PCR) was performed with segment-specific primers as described elsewhere (Hoffmann et al., 2002) . Briefly, RNA was isolated by using the RNeasy kit (Qiagen). RNA was transcribed to cDNA by using Universal 12 primer (AGC AAA AGC AGG), and the cDNA was amplified by using segment-specific primers. Sequencing was performed by the Hartwell Center for Biotechnology at St. Jude Children's Research Hospital, using the rhodamine dye-terminator cycle sequencing Ready Reaction kit with AmpliTaq DNA polymerase FS (Perkin-Elmer Applied Biosystems). Plasmids with different single or combined mutations were created by using the Quick-Change site-directed mutagenesis kit (Stratagene). The amino acid sequences of the HA proteins of each virus were aligned with that of A/Aichi/2/68 (H3N2) and numbered (H3 numbering) on the basis of the X-ray crystallographic structure (Sauter et al., 1992) .
Generation of reassortant viruses by reverse genetics
Recombinant viruses were generated by using the reverse genetics techniques described by Hoffmann et al. (2002) .
Briefly, 1 day before transfection, 293T and MDCK cells were trypsinized and 0.2 × 10 6 to 1 × 10 6 cells of each cell line cocultured. The cocultured cells were transfected with 1 μg of each of 8 cDNA plasmids encoding each gene segment and 18 μl of TransIT-LT1 Transfection Reagent (Mirus Bio Corporation, Madison, WI) made up to a total volume of 1 ml with OptiMEM I and antibiotics. The DNA-lipid complexes were removed after 6 h, and fresh medium was added to the cell cultures. The cells were incubated for an additional 24 h, then 0.5 μg/ml of L-1-(tosylamido-2-phenyl) ethyl chloromethyl ketone (TPCK)-treated trypsin (Worthington Diagnostics, Freehold, NJ) was added. After a total of 72 h of incubation, 300 μl of supernatant was injected into the allantoic cavity of three 10-day-old embryonated chicken eggs, 100 μl per egg, and 1 ml of supernatant was used to infect MDCK cells in monolayer. After 48 h, the allantoic fluid was harvested, RNA was extracted and analyzed by RT-PCR, and each viral segment was partially sequenced to confirm the identity of the reassortant virus.
Virus characterization and serologic assays
Hemagglutination assay
Fifty microliters of 0.5% CRBC or TRBC in suspension in phosphate-buffered saline (PBS) were added to 50 μl of 2fold dilutions of virus in PBS, and the mixture was incubated at room temperature for 45 min. The hemagglutination titer was calculated as the reciprocal value of the highest virus dilution that caused complete hemagglutination.
Measurement of NA activity
The activity of NA was determined by using a modified fluorometric assay with the fluorogenic substrate 2′-(4methylumbelliferyl)-D-N-acetylneuraminic acid (MUNANA; Sigma) (Gubareva et al., 2002; Potier et al., 1979) . The fluorescence of the released 4-methylumbelliferone was measured in a Fluoroskan II (Labsystems, Helsinki, Finland) spectrophotometer using excitation and emission wavelengths of 355 and 460 nm, respectively. Enzyme activity was expressed as the quantity of fluorogenic substrates being released (relative emission units at 460 nm). All reactions were performed twice.
HI and NI assays
The antigenicity of the virus isolates was characterized by using the HI test (Aymard-Henry et al., 1973) with antisera and monoclonal antibodies (mAbs) against H3, H1, N1, and N2 subtypes. For the HI assay, we used sheep antiserum to A/ Wyoming/03/2003-like virus (H3 antiserum), goat anti-PR8 serum (H1 antiserum), murine monoclonal anti-A/Memphis/1/ 94 (H3 mAbs), and pooled murine mAbs to A/WSN/33 (H1 mAbs). For the NI assay, we used goat antiserum to A/New Jersey/8/76 (N1 antiserum) and A/Singapore/1/57 (N2 antiserum), murine mAb to A/WSN/33 (N1 mAb), and pooled murine mAbs to A/Memphis/2/85 and A/Memphis/12/85 (N2 mAbs). H3 antiserum was obtained from the Centers for Disease Control and Prevention (CDC), Atlanta, GA, and all other antisera and mAbs were obtained from the St. Jude Children's Research Hospital repository.
Plaque assay
Plaque assay (Hayden et al., 1980) was performed to determine virus titer and plaque phenotype. Briefly, confluent monolayers of MDCK cells were inoculated with 10-fold dilutions of influenza virus. After 1 h at 37°C, the inoculum was removed and the cells were washed and overlaid with maintenance medium containing 1% agarose, 0.2% serum albumin, and 2.5 μg/ml of TPCK-treated trypsin (Worthington). After 3 days of incubation at 37°C in a humidified atmosphere of 5% CO 2 , the cells were stained with 0.1% crystal violet in 37% formaldehyde.
Assay of virus binding to substrates containing SA
The binding of human influenza viruses to fetuin was performed in a direct solid-phase assay using the immobilized virus and horseradish-peroxidase (HRP)-conjugated fetuin, as described previously (Gambaryan and Matrosovich, 1992) . The affinity of viruses to p3′SL and p6SL was measured in a competitive assay based on the inhibition of binding of the HRP-labeled fetuin (Matrosovich et al., 1993) . The polyvalent synthetic sialoglycoconjugates p3′SL and p6SL were synthesized as described earlier and provided by Dr. N.V. Bovin.
Briefly, 96-well microtiter plates (Costar, Cambridge, MA) were coated with viruses at a titer of 4−8 hemagglutination units at 4°C for 16 h followed by washing with 0.05% Tween 20 in PBS (PBS-T). After the addition of peroxidase-conjugated fetuin or synthetic substrate in PBS supplemented with 0.02% Tween 20, 0.02% BSA, 3 μM of the NA inhibitor 2,3didehydro-2,4-dideoxy-4-amino-N-acetyl-D-neuraminic acid, and, in the case of competitive assay, fetuin, plates were incubated at 4°C for 1 h. The initial concentration of p3′SL or p6SL was 20 μM in SA; 2-fold serial dilutions were used. After washing with cold PBS-T, substrate solution (0.1 M sodium acetate [pH 5.0] containing 4 mM o-phenylendiamine [Boehringer Mannheim, Germany] and 0.004% H 2 O 2 ) was added for 30 min. The reaction was stopped with 2 M H 2 SO 4 . Optical density was determined at 492 nm with a Multiscan plate reader (Labsystems, Finland). The dissociation constants (K diss ) were determined as the SA (Neu5Ac) concentration at the point A max /2 on Scatchard plots. The reported data represent the mean of at least 4 individual experiments for each virus.
